Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.65
+0.02 (0.36%)
Sep 18, 2026, 4:08 PM HKT

HKG:3613 Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3541,5131,6121,5251,7311,556
Revenue Growth
-10.56%-6.10%5.68%-11.91%11.24%18.31%
Gross Profit
847.21925.581,0651,0471,1501,120
Operating Income
426.25476574.06623.91804.49772.13
Net Income
360.55397.22500.28540.39645.88607.84
Earnings Per Share
0.430.470.600.650.770.73
EPS Growth
-9.23%-20.60%-7.42%-16.33%6.26%12.05%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Inter-Segment Elimination
-332.78-336.6-308.86-357.36-469.73-678.32
Overseas
364.16406.46402.62482.44472.26443.6
Mainland China
201.35266.1248.76228.63528.45578.8
Hong Kong
1,1211,1771,2691,1711,2001,212
Total
1,3541,5131,6121,5251,7311,556

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,2172,2901,8332,3982,2622,293
Total Debt
125.8126.54123.42131.81103.08128.48
Net Cash (Debt)
2,0922,1641,7102,2662,1592,165
Net Cash Growth
-3.34%26.57%-24.57%4.96%-0.26%22.98%
Net Cash Per Share
2.502.582.042.712.582.59

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
621.93829.52-217.25460.83547.44777.17
Capital Expenditures
-27.41-41.18-43.17-21.87-38.51-23.43
Free Cash Flow
594.53788.34-260.42438.97508.94753.74
Free Cash Flow Growth
-24.59%---13.75%-32.48%630.55%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.59%61.16%66.10%68.67%66.44%71.95%
Operating Margin
31.49%31.45%35.62%40.91%46.47%49.62%
Pretax Margin
33.13%33.35%39.08%45.10%47.71%50.02%
Profit Margin
26.64%26.25%31.04%35.44%37.31%39.06%
FCF Margin
43.92%52.09%-16.16%28.79%29.40%48.44%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3700.3700.3500.3300.3300.280
Dividend Per Share Growth
14.29%5.71%6.06%0%17.86%16.67%
Dividend Yield
6.55%4.64%4.40%3.11%3.36%2.57%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.1117.8314.6918.8114.8518.48
Forward PE
10.6512.3510.5312.3715.4317.23
P/FCF Ratio
7.958.98-23.1518.8514.90
PS Ratio
3.494.684.566.665.547.22